Medina Padilla, Miguel,Dominguez Correa, Juan Manuel,De Cristobal Blanco, Javier,Fuertes Huerta, Ana,Sanchez-Quesada, Jorge,Lopez Ogalla, Javier,Herrero Santos, Susana,Perez De La Cruz Moreno, Maria A
申请号：
AU2013224041
公开号：
AU2013224041A1
申请日:
2013.02.22
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention relates to new thiadiazolidmediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.
